NBRV logo

Nabriva Therapeutics (NBRV) Revenue

Annual Revenue

$35.67 M
+$8.45 M+31.06%

December 31, 2022


Summary


Performance

NBRV Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNBRVprofitabilitymetrics:

Quarterly Revenue

$7.59 M
-$2.85 M-27.29%

March 31, 2023


Summary


Performance

NBRV Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

Related metrics

TTM Revenue

$35.59 M
-$79.00 K-0.22%

March 31, 2023


Summary


Performance

NBRV TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherNBRVprofitabilitymetrics:

NBRV Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+31.1%-1.0%+8.7%
3 y3 years+360.4%+2421.6%+404.9%
5 y5 years-+16.8%+359.3%

NBRV Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-23.7%-27.3%at low-0.2%-23.5%
5 y5-yearat high-92.0%-27.3%-100.5%-0.2%-97.0%
alltimeall timeat high-92.0%-27.3%-100.5%-0.2%-97.2%

Nabriva Therapeutics Revenue History

DateAnnualQuarterlyTTM
Mar 2023
-
$7.59 M(-27.3%)
$35.59 M(-0.2%)
Dec 2022
$35.67 M(+31.1%)
$10.44 M(+18.8%)
$35.67 M(+4.5%)
Sep 2022
-
$8.78 M(+0.1%)
$34.14 M(+1.1%)
Jun 2022
-
$8.78 M(+14.4%)
$33.78 M(+3.1%)
Mar 2022
-
$7.67 M(-13.9%)
$32.75 M(+20.3%)
Dec 2021
$27.22 M(+850.3%)
$8.91 M(+5.8%)
$27.22 M(+33.8%)
Sep 2021
-
$8.42 M(+8.6%)
$20.34 M(+62.9%)
Jun 2021
-
$7.75 M(+263.6%)
$12.49 M(+166.0%)
Mar 2021
-
$2.13 M(+4.8%)
$4.70 M(+63.9%)
DateAnnualQuarterlyTTM
Dec 2020
$2.86 M(-63.0%)
$2.04 M(+257.6%)
$2.86 M(+164.9%)
Sep 2020
-
$569.00 K(-1487.8%)
$1.08 M(-84.6%)
Jun 2020
-
-$41.00 K(-113.6%)
$7.01 M(-0.6%)
Mar 2020
-
$301.00 K(+19.4%)
$7.05 M(-9.0%)
Dec 2019
$7.75 M(+19.2%)
$252.00 K(-96.1%)
$7.75 M(+3.4%)
Sep 2019
-
$6.50 M(+549.6%)
$7.50 M(+649.6%)
Mar 2019
-
$1.00 M(-84.6%)
$1.00 M(-84.6%)
Dec 2018
$6.50 M
-
-
Mar 2018
-
$6.50 M
$6.50 M

FAQ

  • What is Nabriva Therapeutics annual revenue?
  • What is the all time high annual revenue for Nabriva Therapeutics?
  • What is Nabriva Therapeutics annual revenue year-on-year change?
  • What is Nabriva Therapeutics quarterly revenue?
  • What is the all time high quarterly revenue for Nabriva Therapeutics?
  • What is Nabriva Therapeutics quarterly revenue year-on-year change?
  • What is Nabriva Therapeutics TTM revenue?
  • What is the all time high TTM revenue for Nabriva Therapeutics?
  • What is Nabriva Therapeutics TTM revenue year-on-year change?

What is Nabriva Therapeutics annual revenue?

The current annual revenue of NBRV is $35.67 M

What is the all time high annual revenue for Nabriva Therapeutics?

Nabriva Therapeutics all-time high annual revenue is $35.67 M

What is Nabriva Therapeutics annual revenue year-on-year change?

Over the past year, NBRV annual revenue has changed by +$8.45 M (+31.06%)

What is Nabriva Therapeutics quarterly revenue?

The current quarterly revenue of NBRV is $7.59 M

What is the all time high quarterly revenue for Nabriva Therapeutics?

Nabriva Therapeutics all-time high quarterly revenue is $10.44 M

What is Nabriva Therapeutics quarterly revenue year-on-year change?

Over the past year, NBRV quarterly revenue has changed by -$79.00 K (-1.03%)

What is Nabriva Therapeutics TTM revenue?

The current TTM revenue of NBRV is $35.59 M

What is the all time high TTM revenue for Nabriva Therapeutics?

Nabriva Therapeutics all-time high TTM revenue is $35.67 M

What is Nabriva Therapeutics TTM revenue year-on-year change?

Over the past year, NBRV TTM revenue has changed by +$2.84 M (+8.66%)